ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Fostamatinib Market Research Report 2024
Published Date: April 2024
|
Report Code: QYRE-Auto-0A11564
Home | Market Reports | Health| Pharmacy
Global Fostamatinib Market Research Report 2022
BUY CHAPTERS

Global Fostamatinib Market Research Report 2024

Code: QYRE-Auto-0A11564
Report
April 2024
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Rigel Pharmaceuticals Inc
Kissei Pharmaceutical Co Ltd
Grifols S A
JW Pharmaceutical Corporation
Astrazeneca plc
Medison Pharma Canada

Fostamatinib Market

The global Fostamatinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Fostamatinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Fostamatinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Fostamatinib include Rigel Pharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, Grifols, JW Pharmaceutical Corporation, Medison Pharma Canada and AstraZeneca, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Fostamatinib, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Fostamatinib.

Report Scope

The Fostamatinib market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Fostamatinib market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Fostamatinib manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Fostamatinib Market Report

Report Metric Details
Report Name Fostamatinib Market
Segment by Type
  • Tavalisse
  • Tavlesse
Segment by Application
  • Idiopathic (Immune) Thrombocytopenic Purpura
  • Waldenström's Macroglobulinemia
  • Autoimmune Haemolytic Anaemia
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Rigel Pharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, Grifols, JW Pharmaceutical Corporation, Medison Pharma Canada, AstraZeneca
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Fostamatinib manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Fostamatinib in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Fostamatinib Market report?

Ans: The main players in the Fostamatinib Market are Rigel Pharmaceuticals, Inc, Kissei Pharmaceutical Co., Ltd, Grifols, JW Pharmaceutical Corporation, Medison Pharma Canada, AstraZeneca

What are the Application segmentation covered in the Fostamatinib Market report?

Ans: The Applications covered in the Fostamatinib Market report are Idiopathic (Immune) Thrombocytopenic Purpura, Waldenström's Macroglobulinemia, Autoimmune Haemolytic Anaemia, Other

What are the Type segmentation covered in the Fostamatinib Market report?

Ans: The Types covered in the Fostamatinib Market report are Tavalisse, Tavlesse

1 Fostamatinib Market Overview
1.1 Product Overview and Scope of Fostamatinib
1.2 Fostamatinib Segment by Type
1.2.1 Global Fostamatinib Market Value Comparison by Type (2024-2030)
1.2.2 Tavalisse
1.2.3 Tavlesse
1.3 Fostamatinib Segment by Application
1.3.1 Global Fostamatinib Market Value by Application: (2024-2030)
1.3.2 Idiopathic (Immune) Thrombocytopenic Purpura
1.3.3 Waldenström's Macroglobulinemia
1.3.4 Autoimmune Haemolytic Anaemia
1.3.5 Other
1.4 Global Fostamatinib Market Size Estimates and Forecasts
1.4.1 Global Fostamatinib Revenue 2019-2030
1.4.2 Global Fostamatinib Sales 2019-2030
1.4.3 Global Fostamatinib Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Fostamatinib Market Competition by Manufacturers
2.1 Global Fostamatinib Sales Market Share by Manufacturers (2019-2024)
2.2 Global Fostamatinib Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Fostamatinib Average Price by Manufacturers (2019-2024)
2.4 Global Fostamatinib Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Fostamatinib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Fostamatinib, Product Type & Application
2.7 Fostamatinib Market Competitive Situation and Trends
2.7.1 Fostamatinib Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Fostamatinib Players Market Share by Revenue
2.7.3 Global Fostamatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Fostamatinib Retrospective Market Scenario by Region
3.1 Global Fostamatinib Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Fostamatinib Global Fostamatinib Sales by Region: 2019-2030
3.2.1 Global Fostamatinib Sales by Region: 2019-2024
3.2.2 Global Fostamatinib Sales by Region: 2025-2030
3.3 Global Fostamatinib Global Fostamatinib Revenue by Region: 2019-2030
3.3.1 Global Fostamatinib Revenue by Region: 2019-2024
3.3.2 Global Fostamatinib Revenue by Region: 2025-2030
3.4 North America Fostamatinib Market Facts & Figures by Country
3.4.1 North America Fostamatinib Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Fostamatinib Sales by Country (2019-2030)
3.4.3 North America Fostamatinib Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Fostamatinib Market Facts & Figures by Country
3.5.1 Europe Fostamatinib Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Fostamatinib Sales by Country (2019-2030)
3.5.3 Europe Fostamatinib Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Fostamatinib Market Facts & Figures by Country
3.6.1 Asia Pacific Fostamatinib Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Fostamatinib Sales by Country (2019-2030)
3.6.3 Asia Pacific Fostamatinib Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Fostamatinib Market Facts & Figures by Country
3.7.1 Latin America Fostamatinib Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Fostamatinib Sales by Country (2019-2030)
3.7.3 Latin America Fostamatinib Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Fostamatinib Market Facts & Figures by Country
3.8.1 Middle East and Africa Fostamatinib Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Fostamatinib Sales by Country (2019-2030)
3.8.3 Middle East and Africa Fostamatinib Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Fostamatinib Sales by Type (2019-2030)
4.1.1 Global Fostamatinib Sales by Type (2019-2024)
4.1.2 Global Fostamatinib Sales by Type (2025-2030)
4.1.3 Global Fostamatinib Sales Market Share by Type (2019-2030)
4.2 Global Fostamatinib Revenue by Type (2019-2030)
4.2.1 Global Fostamatinib Revenue by Type (2019-2024)
4.2.2 Global Fostamatinib Revenue by Type (2025-2030)
4.2.3 Global Fostamatinib Revenue Market Share by Type (2019-2030)
4.3 Global Fostamatinib Price by Type (2019-2030)
5 Segment by Application
5.1 Global Fostamatinib Sales by Application (2019-2030)
5.1.1 Global Fostamatinib Sales by Application (2019-2024)
5.1.2 Global Fostamatinib Sales by Application (2025-2030)
5.1.3 Global Fostamatinib Sales Market Share by Application (2019-2030)
5.2 Global Fostamatinib Revenue by Application (2019-2030)
5.2.1 Global Fostamatinib Revenue by Application (2019-2024)
5.2.2 Global Fostamatinib Revenue by Application (2025-2030)
5.2.3 Global Fostamatinib Revenue Market Share by Application (2019-2030)
5.3 Global Fostamatinib Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Rigel Pharmaceuticals, Inc
6.1.1 Rigel Pharmaceuticals, Inc Corporation Information
6.1.2 Rigel Pharmaceuticals, Inc Description and Business Overview
6.1.3 Rigel Pharmaceuticals, Inc Fostamatinib Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Rigel Pharmaceuticals, Inc Fostamatinib Product Portfolio
6.1.5 Rigel Pharmaceuticals, Inc Recent Developments/Updates
6.2 Kissei Pharmaceutical Co., Ltd
6.2.1 Kissei Pharmaceutical Co., Ltd Corporation Information
6.2.2 Kissei Pharmaceutical Co., Ltd Description and Business Overview
6.2.3 Kissei Pharmaceutical Co., Ltd Fostamatinib Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Kissei Pharmaceutical Co., Ltd Fostamatinib Product Portfolio
6.2.5 Kissei Pharmaceutical Co., Ltd Recent Developments/Updates
6.3 Grifols
6.3.1 Grifols Corporation Information
6.3.2 Grifols Description and Business Overview
6.3.3 Grifols Fostamatinib Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Grifols Fostamatinib Product Portfolio
6.3.5 Grifols Recent Developments/Updates
6.4 JW Pharmaceutical Corporation
6.4.1 JW Pharmaceutical Corporation Corporation Information
6.4.2 JW Pharmaceutical Corporation Description and Business Overview
6.4.3 JW Pharmaceutical Corporation Fostamatinib Sales, Revenue and Gross Margin (2019-2024)
6.4.4 JW Pharmaceutical Corporation Fostamatinib Product Portfolio
6.4.5 JW Pharmaceutical Corporation Recent Developments/Updates
6.5 Medison Pharma Canada
6.5.1 Medison Pharma Canada Corporation Information
6.5.2 Medison Pharma Canada Description and Business Overview
6.5.3 Medison Pharma Canada Fostamatinib Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Medison Pharma Canada Fostamatinib Product Portfolio
6.5.5 Medison Pharma Canada Recent Developments/Updates
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Description and Business Overview
6.6.3 AstraZeneca Fostamatinib Sales, Revenue and Gross Margin (2019-2024)
6.6.4 AstraZeneca Fostamatinib Product Portfolio
6.6.5 AstraZeneca Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Fostamatinib Industry Chain Analysis
7.2 Fostamatinib Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Fostamatinib Production Mode & Process
7.4 Fostamatinib Sales and Marketing
7.4.1 Fostamatinib Sales Channels
7.4.2 Fostamatinib Distributors
7.5 Fostamatinib Customers
8 Fostamatinib Market Dynamics
8.1 Fostamatinib Industry Trends
8.2 Fostamatinib Market Drivers
8.3 Fostamatinib Market Challenges
8.4 Fostamatinib Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Rigel Pharmaceuticals Inc
Kissei Pharmaceutical Co Ltd
Grifols S A
JW Pharmaceutical Corporation
Astrazeneca plc
Medison Pharma Canada
List of Tables
    Table 1. Global Fostamatinib Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Fostamatinib Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Fostamatinib Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Fostamatinib Sales (K Bottles) of Key Manufacturers (2019-2024)
    Table 5. Global Fostamatinib Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Fostamatinib Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Fostamatinib Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Fostamatinib Average Price (US$/Bottle) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Fostamatinib, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Fostamatinib, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Fostamatinib, Product Type & Application
    Table 12. Global Key Manufacturers of Fostamatinib, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Fostamatinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Fostamatinib as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Fostamatinib Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Fostamatinib Sales by Region (2019-2024) & (K Bottles)
    Table 18. Global Fostamatinib Sales Market Share by Region (2019-2024)
    Table 19. Global Fostamatinib Sales by Region (2025-2030) & (K Bottles)
    Table 20. Global Fostamatinib Sales Market Share by Region (2025-2030)
    Table 21. Global Fostamatinib Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Fostamatinib Revenue Market Share by Region (2019-2024)
    Table 23. Global Fostamatinib Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Fostamatinib Revenue Market Share by Region (2025-2030)
    Table 25. North America Fostamatinib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Fostamatinib Sales by Country (2019-2024) & (K Bottles)
    Table 27. North America Fostamatinib Sales by Country (2025-2030) & (K Bottles)
    Table 28. North America Fostamatinib Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Fostamatinib Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Fostamatinib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Fostamatinib Sales by Country (2019-2024) & (K Bottles)
    Table 32. Europe Fostamatinib Sales by Country (2025-2030) & (K Bottles)
    Table 33. Europe Fostamatinib Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Fostamatinib Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Fostamatinib Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Fostamatinib Sales by Region (2019-2024) & (K Bottles)
    Table 37. Asia Pacific Fostamatinib Sales by Region (2025-2030) & (K Bottles)
    Table 38. Asia Pacific Fostamatinib Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Fostamatinib Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Fostamatinib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Fostamatinib Sales by Country (2019-2024) & (K Bottles)
    Table 42. Latin America Fostamatinib Sales by Country (2025-2030) & (K Bottles)
    Table 43. Latin America Fostamatinib Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Fostamatinib Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Fostamatinib Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Fostamatinib Sales by Country (2019-2024) & (K Bottles)
    Table 47. Middle East & Africa Fostamatinib Sales by Country (2025-2030) & (K Bottles)
    Table 48. Middle East & Africa Fostamatinib Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Fostamatinib Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Fostamatinib Sales (K Bottles) by Type (2019-2024)
    Table 51. Global Fostamatinib Sales (K Bottles) by Type (2025-2030)
    Table 52. Global Fostamatinib Sales Market Share by Type (2019-2024)
    Table 53. Global Fostamatinib Sales Market Share by Type (2025-2030)
    Table 54. Global Fostamatinib Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Fostamatinib Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Fostamatinib Revenue Market Share by Type (2019-2024)
    Table 57. Global Fostamatinib Revenue Market Share by Type (2025-2030)
    Table 58. Global Fostamatinib Price (US$/Bottle) by Type (2019-2024)
    Table 59. Global Fostamatinib Price (US$/Bottle) by Type (2025-2030)
    Table 60. Global Fostamatinib Sales (K Bottles) by Application (2019-2024)
    Table 61. Global Fostamatinib Sales (K Bottles) by Application (2025-2030)
    Table 62. Global Fostamatinib Sales Market Share by Application (2019-2024)
    Table 63. Global Fostamatinib Sales Market Share by Application (2025-2030)
    Table 64. Global Fostamatinib Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Fostamatinib Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Fostamatinib Revenue Market Share by Application (2019-2024)
    Table 67. Global Fostamatinib Revenue Market Share by Application (2025-2030)
    Table 68. Global Fostamatinib Price (US$/Bottle) by Application (2019-2024)
    Table 69. Global Fostamatinib Price (US$/Bottle) by Application (2025-2030)
    Table 70. Rigel Pharmaceuticals, Inc Corporation Information
    Table 71. Rigel Pharmaceuticals, Inc Description and Business Overview
    Table 72. Rigel Pharmaceuticals, Inc Fostamatinib Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2019-2024)
    Table 73. Rigel Pharmaceuticals, Inc Fostamatinib Product
    Table 74. Rigel Pharmaceuticals, Inc Recent Developments/Updates
    Table 75. Kissei Pharmaceutical Co., Ltd Corporation Information
    Table 76. Kissei Pharmaceutical Co., Ltd Description and Business Overview
    Table 77. Kissei Pharmaceutical Co., Ltd Fostamatinib Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2019-2024)
    Table 78. Kissei Pharmaceutical Co., Ltd Fostamatinib Product
    Table 79. Kissei Pharmaceutical Co., Ltd Recent Developments/Updates
    Table 80. Grifols Corporation Information
    Table 81. Grifols Description and Business Overview
    Table 82. Grifols Fostamatinib Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2019-2024)
    Table 83. Grifols Fostamatinib Product
    Table 84. Grifols Recent Developments/Updates
    Table 85. JW Pharmaceutical Corporation Corporation Information
    Table 86. JW Pharmaceutical Corporation Description and Business Overview
    Table 87. JW Pharmaceutical Corporation Fostamatinib Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2019-2024)
    Table 88. JW Pharmaceutical Corporation Fostamatinib Product
    Table 89. JW Pharmaceutical Corporation Recent Developments/Updates
    Table 90. Medison Pharma Canada Corporation Information
    Table 91. Medison Pharma Canada Description and Business Overview
    Table 92. Medison Pharma Canada Fostamatinib Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2019-2024)
    Table 93. Medison Pharma Canada Fostamatinib Product
    Table 94. Medison Pharma Canada Recent Developments/Updates
    Table 95. AstraZeneca Corporation Information
    Table 96. AstraZeneca Description and Business Overview
    Table 97. AstraZeneca Fostamatinib Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2019-2024)
    Table 98. AstraZeneca Fostamatinib Product
    Table 99. AstraZeneca Recent Developments/Updates
    Table 100. Key Raw Materials Lists
    Table 101. Raw Materials Key Suppliers Lists
    Table 102. Fostamatinib Distributors List
    Table 103. Fostamatinib Customers List
    Table 104. Fostamatinib Market Trends
    Table 105. Fostamatinib Market Drivers
    Table 106. Fostamatinib Market Challenges
    Table 107. Fostamatinib Market Restraints
    Table 108. Research Programs/Design for This Report
    Table 109. Key Data Information from Secondary Sources
    Table 110. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Fostamatinib
    Figure 2. Global Fostamatinib Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Fostamatinib Market Share by Type in 2023 & 2030
    Figure 4. Tavalisse Product Picture
    Figure 5. Tavlesse Product Picture
    Figure 6. Global Fostamatinib Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Fostamatinib Market Share by Application in 2023 & 2030
    Figure 8. Idiopathic (Immune) Thrombocytopenic Purpura
    Figure 9. Waldenström's Macroglobulinemia
    Figure 10. Autoimmune Haemolytic Anaemia
    Figure 11. Other
    Figure 12. Global Fostamatinib Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Fostamatinib Market Size (2019-2030) & (US$ Million)
    Figure 14. Global Fostamatinib Sales (2019-2030) & (K Bottles)
    Figure 15. Global Fostamatinib Average Price (US$/Bottle) & (2019-2030)
    Figure 16. Fostamatinib Report Years Considered
    Figure 17. Fostamatinib Sales Share by Manufacturers in 2023
    Figure 18. Global Fostamatinib Revenue Share by Manufacturers in 2023
    Figure 19. The Global 5 and 10 Largest Fostamatinib Players: Market Share by Revenue in 2023
    Figure 20. Fostamatinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 21. Global Fostamatinib Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 22. North America Fostamatinib Sales Market Share by Country (2019-2030)
    Figure 23. North America Fostamatinib Revenue Market Share by Country (2019-2030)
    Figure 24. United States Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 25. Canada Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 26. Europe Fostamatinib Sales Market Share by Country (2019-2030)
    Figure 27. Europe Fostamatinib Revenue Market Share by Country (2019-2030)
    Figure 28. Germany Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. France Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. U.K. Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Italy Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 32. Russia Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. Asia Pacific Fostamatinib Sales Market Share by Region (2019-2030)
    Figure 34. Asia Pacific Fostamatinib Revenue Market Share by Region (2019-2030)
    Figure 35. China Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Japan Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. South Korea Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. India Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Australia Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. China Taiwan Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Indonesia Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Thailand Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Malaysia Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Latin America Fostamatinib Sales Market Share by Country (2019-2030)
    Figure 45. Latin America Fostamatinib Revenue Market Share by Country (2019-2030)
    Figure 46. Mexico Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Brazil Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Argentina Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Middle East & Africa Fostamatinib Sales Market Share by Country (2019-2030)
    Figure 50. Middle East & Africa Fostamatinib Revenue Market Share by Country (2019-2030)
    Figure 51. Turkey Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Saudi Arabia Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. UAE Fostamatinib Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Global Sales Market Share of Fostamatinib by Type (2019-2030)
    Figure 55. Global Revenue Market Share of Fostamatinib by Type (2019-2030)
    Figure 56. Global Fostamatinib Price (US$/Bottle) by Type (2019-2030)
    Figure 57. Global Sales Market Share of Fostamatinib by Application (2019-2030)
    Figure 58. Global Revenue Market Share of Fostamatinib by Application (2019-2030)
    Figure 59. Global Fostamatinib Price (US$/Bottle) by Application (2019-2030)
    Figure 60. Fostamatinib Value Chain
    Figure 61. Fostamatinib Production Process
    Figure 62. Channels of Distribution (Direct Vs Distribution)
    Figure 63. Distributors Profiles
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

Fostamatinib Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anlotinib Market Research Report 2024
Global Afatinib Market Research Report 2024
Global Neratinib Market Research Report 2024
Global Pazopanib Market Research Report 2024
Global Talazoparib Market Research Report 2024
Global Erlotinib Market Research Report 2024
Global Trametinib Market Research Report 2025
Global Tucatinib Market Research Report 2025
Global Crizotinib Market Research Report 2024
Global Apatinib Market Research Report 2024
Global Ibrutinib Market Research Report 2024
Global Ceritinib Market Research Report 2024
Global Gefitinib Market Research Report 2024
Global Daratumumab Market Research Report 2024
Global Sunitinib Malate Market Research Report 2025
Global Nintedanib Market Research Report 2024
Global Axitinib Market Research Report 2025
Global Alectinib Market Research Report 2024
Global Pazopanib Tablets Market Research Report 2024

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions